Clinical Trials Browser

Lymphoma, Mantle-Cell × Standard of Care × Clear all

NCT03219047 2023-07-27

Patient-Derived Xenografts in Personalizing Treatment for Patients With Relapsed/Refractory Mantle Cell Lymphoma

Phase EARLY_PHASE1 Completed

Lymphoma, Mantle-Cell